Lv1
30 积分 2022-12-15 加入
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
3小时前
待确认
饮食管理对慢性肾脏病患者影响效果的系统评价
2个月前
已完结
A Phase I, Open-Label, Mass Balance Study of [14C]-Iberdomide in Healthy Subjects
7个月前
已完结
Recommendations for Dose Selection for Adolescent Patients in Relevant Adult Oncology Clinical Trials
2年前
已完结
皖公网安备34019202002308
